Avanos Net Income Per Share from 2010 to 2024

AVNS Stock  USD 17.00  0.00  0.00%   
Avanos Medical Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss is likely to outpace its year average in 2024. From the period from 2010 to 2024, Avanos Medical Net Loss quarterly data regression had mean square error of  9.06 and mean deviation of  2.02. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(1.33)
Current Value
(1.26)
Quarterly Volatility
3.09201855
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Avanos Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avanos Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43 M, Interest Expense of 16.1 M or Selling General Administrative of 286.2 M, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.26 or PTB Ratio of 1.45. Avanos financial statements analysis is a perfect complement when working with Avanos Medical Valuation or Volatility modules.
  
Check out the analysis of Avanos Medical Correlation against competitors.
For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Latest Avanos Medical's Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of Avanos Medical over the last few years. It is Avanos Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avanos Medical's overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Slightly volatile
   Net Income Per Share   
       Timeline  

Avanos Net Income Per Share Regression Statistics

Arithmetic Mean0.33
Coefficient Of Variation923.23
Mean Deviation2.02
Median0.85
Standard Deviation3.09
Sample Variance9.56
Range12.4747
R-Value(0.35)
Mean Square Error9.06
R-Squared0.12
Significance0.21
Slope(0.24)
Total Sum of Squares133.85

Avanos Net Income Per Share History

2024 -1.26
2023 -1.33
2022 1.08
2021 0.13
2020 -0.57
2019 -0.96
2018 1.22

About Avanos Medical Financial Statements

Avanos Medical shareholders use historical fundamental indicators, such as Net Income Per Share, to determine how well the company is positioned to perform in the future. Although Avanos Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Avanos Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Avanos Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss(1.33)(1.26)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.